All News about Better Therapeutics, Inc. - Common Stock
![](https://mms.businesswire.com/media/20221114005259/en/1634959/5/Better_Tx_640x360_Logo.jpg)
![](https://mms.businesswire.com/media/20221107005117/en/1626231/5/Better_Tx_640x360_Logo.jpg)
![](https://mms.businesswire.com/media/20221027005408/en/1616029/4/Better_therapeutics_white_bg_-_no_clear_space.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/09/22/aapharma_8.png?width=1200&height=800&fit=crop)
Better Therapeutics Seeks FDA Approval For First Digital Therapeutic For Type 2 Diabetes
September 22, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/07/28/aapharma_7.png?width=1200&height=800&fit=crop)
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2019/07/insider1600.jpg)
![](https://mms.businesswire.com/media/20221004005347/en/1590725/5/Better_Tx_640x360_Logo.jpg)
![](https://mms.businesswire.com/media/20220922005274/en/1579861/4/Better_therapeutics_white_bg_-_no_clear_space_%28002%29.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/09/20/image_4.jpg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/09/16/image27.jpeg?width=1200&height=800&fit=crop)
Bridgeline Digital And 2 Other Penny Stocks Insiders Are Aggressively Buying
September 16, 2022
Via Benzinga
![](https://mms.businesswire.com/media/20220907005541/en/1563448/5/Better_Tx_640x360_Logo.jpg)
Better Therapeutics to Participate in Three Upcoming Investor Conferences
September 07, 2022
From Better Therapeutics
Via Business Wire
![](https://investorplace.com/wp-content/uploads/2021/04/wall-street-pre-market.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/08/23/image-amazon-3.jpg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/08/22/image-amc_entertainment.jpg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://mms.businesswire.com/media/20220811005186/en/1541519/5/Better_Tx_640x360_Logo.jpg)
![](https://mms.businesswire.com/media/20220804005116/en/1534119/5/Better_Tx_640x360_Logo.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_13880.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/08/03/image30.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/08/02/image-applied-dna-sciences.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/07/28/bz-pharma_4.jpg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/08/02/image-revlon.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/07/29/image49.jpg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_13580.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/07/28/image40.jpg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2022/04/hydrogen-station.png)
![](https://investorplace.com/wp-content/uploads/2021/01/diabetes-stocks.png)
![](https://cdn.benzinga.com/files/images/story/2022/07/28/bz-pharma.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_13530.jpeg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20220728005143/en/1526755/5/Better_Tx_640x360_Logo.jpg)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.